EFFICACY AND SAFETY OF GUSELKUMAB FOR CROHN’S DISEASE THROUGH 3 YEARS: GALAXI-1 LONG-TERM EXTENSION

Anita Afzali  1     Silvio Danese  2     Remo Panaccione  3     Brian G. Feagan  4     David T. Rubin  5     Bruce E. Sands  6     Walter Reinisch  7     Julian Panés  8     Aparna Sahoo  9     Natalie Terry  9     Leonardo Salese  9     Christopher Corbett  10     Tadakazu Hisamatsu  11     Jane Andrews  12     Geert R. D'Haens  13    
1 University of Cincinnati, Cincinnati, United States
2 Vita-Salute San Raffaele University - IRCCS San Raffaele Scientific Institute, Milan, Netherlands
3 University of Calgary, Calgary, Canada
4 The University of Western Ontario, London, Canada
5 University of Chicago Medicine, Chicago, United States
6 Icahn School of Medicine at Mount Sinai, New York, United States
7 Medical University of Vienna, Wien, Austria
8 Hospital Clínic Barcelona, Barcelona, Spain
9 Janssen, Spring House, United States
10 Janssen UK, Wycombe, United Kingdom
11 Kyorin University, Tokyo, Japan
12 Royal Adelaide Hospital, Adelaide, Australia
13 AMC Amsterdam Inflammatory Bowel Disease Centre - Academic Medical Center, AMC Amsterdam Inflammator, Amsterdam, Netherlands

Topic
Endoscopy, IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing